Showing results (281-290 of 339) with videos related to

Sort By:
Pageof 34
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2011
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trialWilliam R Lumry, H Henry Li, Robyn J Levy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2025
Pharmacokinetics and Pharmacodynamics of neffy, Epinephrine Nasal Spray, in Pediatric Allergy PatientsDavid M Fleischer, H Henry Li, Neetu Talreja, et al.
Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.
The Journal of Clinical Investigation|January 22, 2026
Dermal fibroblasts respond to interleukin-4 and 13 and promote T-cell recruitment in atopic dermatitisTomofumi Numata, Michael Shia, Yoshiyuki Nakamura, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
Vaccine|October 19, 2020
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional surveyRan D Goldman, Tyler D Yan, Michelle Seiler, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Advances in Therapy|May 20, 2026
Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary AngioedemaMarc A Riedl, Nihal Narsipur, Douglas Jones, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
The New England Journal of Medicine|October 6, 2006
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitisPeter S Creticos, John T Schroeder, Robert G Hamilton, et al.
Pageof 34